P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease

por Hauser, Robert A., Giladi, Nir, Poewe, Werner, Brotchie, Jonathan, Friedman, Hadas, Oren, Sheila, Litman, Pninit
Publicado 2022

Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized Study

por Olanow, C. Warren, Espay, Alberto J., Stocchi, Fabrizio, Ellenbogen, Aaron L., Leinonen, Mika, Adar, Liat, Case, Ryan J., Orenbach, Shir Fuchs, Yardeni, Tami, Oren, Sheila, Poewe, Werner
Publicado 2021

Subcutaneous Levodopa Infusion for Parkinson's Disease: 1‐Year Data from the Open‐Label BeyoND Study

por Poewe, Werner, Stocchi, Fabrizio, Arkadir, David, Ebersbach, Georg, Ellenbogen, Aaron L., Giladi, Nir, Isaacson, Stuart H., Kieburtz, Karl, LeWitt, Peter, Olanow, C. Warren, Simuni, Tanya, Thomas, Astrid, Zlotogorski, Abraham, Adar, Liat, Case, Ryan, Oren, Sheila, Fuchs Orenbach, Shir, Rosenfeld, Olivia, Sasson, Nissim, Yardeni, Tami, Espay, Alberto J.
Publicado 2021